Efficacy and safety of the third-generation chloroethylnitrosourea fotemustine for the treatment of chemorefractory T-cell lymphomas

Patients with recurring T-cell non-Hodgkin lymphoma (T-NHL) are incurable and candidate for investigational agents. Here, we report on five patients with T-NHL refractory to multiple chemotherapy lines, including in all cases alkylators and gemcitabine, who received the third-generation chloroethyln...

Descripción completa

Detalles Bibliográficos
Autores principales: Corazzelli, Gaetano, Frigeri, Ferdinando, Arcamone, Manuela, Aloj, Luigi, Capobianco, Gaetana, Becchimanzi, Cristina, Morelli, Emanuela, Volzone, Francesco, Marcacci, Gianpaolo, Russo, Filippo, De Filippi, Rosaria, Lastoria, Secondo, Pinto, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2011
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3263425/
https://www.ncbi.nlm.nih.gov/pubmed/21752099
http://dx.doi.org/10.1111/j.1600-0609.2011.01683.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3263425/
https://www.ncbi.nlm.nih.gov/pubmed/21752099
http://dx.doi.org/10.1111/j.1600-0609.2011.01683.x

Ejemplares similares